Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study

Lubomirov, Rubin; Colombo, Sara; di Iulio, Julia; Ledergerber, Bruno; Martinez, Raquel; Cavassini, Matthias; Hirschel, Bernard; Bernasconi, Enos; Elzi, Luigia; Vernazza, Pietro; Furrer, Hansjakob; Günthard, Huldrych F; Telenti, Amalio; Swiss HIV Cohort Study, (2011). Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study. Journal of infectious diseases, 203(2), pp. 246-57. Cary, N.C.: Oxford University Press 10.1093/infdis/jiq043

[img]
Preview
Text
jiq043.pdf - Published Version
Available under License Publisher holds Copyright.

Download (265kB) | Preview

Poor tolerance and adverse drug reactions are main reasons for discontinuation of antiretroviral therapy (ART). Identifying predictors of ART discontinuation is a priority in HIV care.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Furrer, Hansjakob

ISSN:

0022-1899

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:12

Last Modified:

27 Apr 2018 09:05

Publisher DOI:

10.1093/infdis/jiq043

PubMed ID:

21288825

Web of Science ID:

000286172900016

BORIS DOI:

10.7892/boris.2698

URI:

https://boris.unibe.ch/id/eprint/2698 (FactScience: 205565)

Actions (login required)

Edit item Edit item
Provide Feedback